Clinical Trial Update: Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 proof-of-concept trial evaluating treprostinil delivered via iontophoresis for systemic sclerosis-related digital ulcers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scleroderma
• Systemic Sclerosis

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: University Hospital, Grenoble | Conditions: Scleroderma, Systemic | Phase 1, Phase 2 | Status: COMPLETED